Uroliths composed of antiviral compound GS-441524 in 2 cats undergoing treatment for feline infectious peritonitis
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.16954 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Marissa Allinder und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Veterinary Pharmacy, Charleston Veterinary Referral Center, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Feline Infectious Peritonitis, Ureteral Obstruction, Urinary Calculi, Urolithiasis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Feline infectious peritonitis (FIP) historically has been a fatal disease in cats. Recent unlicensed use of antiviral medication has been shown to markedly improve survival of this infection. An 8-month-old female spayed domestic short-haired cat undergoing treatment for presumptive FIP with the antiviral nucleoside analog GS-441524 developed acute progressive azotemia. Abdominal ultrasound examination identified multifocal urolithiasis including renal, ureteral, and cystic calculi. Unilateral ureteral obstruction progressed to suspected bilateral ureteral obstruction and subcutaneous ureteral bypass (SUB) was performed along with urolith removal and submission for analysis. A 2-year-old male neutered domestic medium-haired cat undergoing treatment for confirmed FIP with GS-441524 developed dysuria (weak urine stream, urinary incontinence, and difficulty expressing the urinary bladder). This cat also was diagnosed sonographically with multifocal urolithiasis requiring temporary tube cystostomy after cystotomy and urolith removal. In both cases, initial urolith analysis showed unidentified material. Additional testing confirmed the calculi in both cats to be 98% consistent with GS-441524. Additional clinical studies are required to determine best screening practices for cats presented for urolithiasis during treatment with GS-441524.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Veterinary Pharmacy, Charleston Veterinary Referral Center, Charleston, South Carolina, USA.
- Critical Care, Charleston Veterinary Referral Center, Charleston, South Carolina, USA.
- Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
- Dept. of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, USA.
- Louis C. Herring & Company, Orlando, Florida, USA.
ORCID-Profile: Marissa Allinder, Bianca N Lourenço
Zitieren
APA
Allinder, M., Tynan, B., Martin, C., Furbish, A., Austin, G., Bartges, J., & Lourenço, B. N. (2024). Uroliths composed of antiviral compound GS-441524 in 2 cats undergoing treatment for feline infectious peritonitis. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16954
Vancouver
Allinder M, Tynan B, Martin C, Furbish A, Austin G, Bartges J, et al. Uroliths composed of antiviral compound GS-441524 in 2 cats undergoing treatment for feline infectious peritonitis. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.16954
BibTeX
@article{Allinder2024,
author = {Allinder, Marissa and Tynan, Beth and Martin, Cara and Furbish, Amelia and Austin, Glenn and Bartges, Joe and Lourenço, Bianca N},
title = {Uroliths composed of antiviral compound GS-441524 in 2 cats undergoing treatment for feline infectious peritonitis},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.16954}
}
EUVIMED